Dr. Lin, Yi-Ling 's orcid link picture Dr. Lin, Yi-Ling 's publons link picture

Dr. Lin, Yi-Ling

Distinguished Research Fellow
Division Chief
  • 02-2789-9013 (Lab) (Room No: 443)
  • 02-2652-3902
  • 02-2785-8847 (Fax)
Specialty:
  • Molecular Virology
  • Viral Pathogenesis
  • Viral Immunology
Education and Positions:

  • 1992/12, PhD, University of California, Los Angeles (UCLA), USA

    2014/7-2018/9, Deputy Director, IBMS, AS, Taipei, Taiwan

    2020/9-2024/8, CEO, Emerging Infectious Disease Division (EIDD), Biomedical Translation Research Center (BioTReC), AS, Taipei, Taiwan

Dr. Lin, Yi-Ling 's
Publications

Journal 141 Book 0

  1. Lee IJ, Lan YH, Wu PY, Wu YW, Chen YH, Tseng SC, Kuo TJ, Sun CP, Jan JT, Ma HH, Liao CC, Liang JJ, Ko HY, Chang CS, Liu WC, Ko YA, Chen YH, Sie ZL, Tsung SI, Lin YL, Wang IH, Tao MH A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern.. Emerging microbes & infections 12(1), 2149353 (2023-12) [JCR] [WOS]
  2. Yang CF, Liao CC, Hsu HW, Liang JJ, Chang CS, Ko HY, Chang RH, Tang WC, Chang MH, Wang IH, Lin YL Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission.. Journal of biomedical science 30(1), 87 (2023-10) [JCR] [WOS]
  3. Chiang HL, Liang KH, Lu RM, Kuo TW, Lin YL, Wu HC Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2.. Journal of biomedical science 30(1), 59 (2023-07) [JCR] [WOS]
  4. Yang CW, Hsu HY, Lee YZ, Jan JT, Chang SY, Lin YL, Yang RB, Chao TL, Liang JJ, Lin SJ, Liao CC, Chang CS, Sytwu HK, Hung MS, Chen CT, Lee SJ Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin.. Biochemical pharmacology 215, 115688 (2023-07) [JCR] [WOS]
  5. Huang YF, Hsu FC, Wu JJ, Lin YL, Liu MT, Yang CH, Kuo HS, Chen YJ, Cheng CY, Lin HH, Liao CC, Chang CS, Liang JJ, Cheng WY, Huang JC, Chen CP, Cheng SH, Lin YC, Yang SH, Chou YJ Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan.. Journal of microbiology, immunology, and infection 56(3), 506-515 (2023-06) [JCR] [WOS]
  6. Yen LC, Chen HW, Ho CL, Lin CC, Lin YL, Yang QW, Chiu KC, Lien SP, Lin RJ, Liao CL Neutralizing antibodies targeting a novel epitope on envelope protein exhibited broad protection against flavivirus without risk of disease enhancement.. Journal of biomedical science 30(1), 41 (2023-06) [JCR] [WOS]
  7. Ko HY, Li YT, Li YY, Chiang MT, Lee YL, Liu WC, Liao CC, Chang CS, Lin YL Optimization and Improvement of qPCR Detection Sensitivity of SARS-CoV-2 in Saliva.. Microbiology spectrum 11(3), e0464022 (2023-05) [JCR] [WOS]
  8. Lu RM, Liang KH, Chiang HL, Hsu FF, Lin HT, Chen WY, Ke FY, Kumari M, Chou YC, Tao MH, Yi-Ling Lin, Wu HC Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice.. Heliyon 9(5), e15587 (2023-04) [JCR] [WOS]
  9. Huang HC, Wang SH, Fang GC, Chou WC, Liao CC, Sun CP, Jan JT, Ma HH, Ko HY, Ko YA, Chiang MT, Liang JJ, Kuo CT, Lee TA, Morales-Scheihing D, Shen CY, Chen SY, McCullough LD, Cui L, Wernig G, Tao MH, Lin YL, Chang YM, Wang SP, Lai YJ, Li CW Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasion.. Journal of medical virology 95(2), e28478 (2023-01) [JCR] [WOS]
  10. Wang S, Wang CY, Kuo HK, Peng WJ, Huang JH, Kuo BS, Lin F, Liu YJ, Liu Z, Wu HT, Ding S, Hou KL, Cheng J, Yang YT, Jiang MH, Wang MS, Chen T, Xia WG, Lin E, Hung CH, Chen HJ, Shih Z, Lin YL, Ryan V, Hu MM, Heppner DG, Malherbe DC, Periasamy S, Kuzmina N, Subramani C, Hellerstein M, Monath TP, Rumyantsev A, Bukreyev A, Guirakhoo F A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2.. Emerging microbes & infections 11(1), 2724-2734 (2022-12) [JCR] [WOS]
Dr. Chern, Yijuang's Lab